Stock Events

Stock Events

Bio-Rad Laboratories 

$365.08
117
+$28.08+8.33% Friday 13:46

Statistics

Day High
365.08
Day Low
365.08
52W High
365.08
52W Low
244.54
Volume
85
Avg. Volume
27
Mkt Cap
9.76B
P/E Ratio
49.75
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.73
2.06
2.38
2.71
Expected EPS
2.230942
Actual EPS
N/A

Financials

29.42%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.58BRevenue
759.9MNet Income

Analyst Ratings

350.00Average Price Target
The highest estimate is 390.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
33%
Hold
67%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIO-B. It's not an investment recommendation.
Apple
42
AAPL
Amazon
38
AMZN
Microsoft
37
MSFT
Alphabet
34
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap232.67B
Thermo Fisher Scientific offers a broad range of products and services in the life sciences sector, directly competing with Bio-Rad's offerings in laboratory equipment and consumables.
Danaher
DHR
Mkt Cap153.85B
Danaher Corporation operates in similar segments as Bio-Rad, including life sciences and diagnostics, making them direct competitors in multiple product lines.
Illumina
ILMN
Mkt Cap33.13B
Illumina specializes in genomics and DNA sequencing technologies, competing with Bio-Rad's products in the genomics field.
Agilent Technologies
A
Mkt Cap44.91B
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Bio-Rad Laboratories Class B shares represent a different class of stock of the same company but are listed separately, directly tied to the company's performance.
Waters
WAT
Mkt Cap40.35B
Waters Corporation provides analytical instruments for the life sciences sector, competing with Bio-Rad's chromatography and mass spectrometry products.
Bruker
BRKR
Mkt Cap9.07B
Bruker Corporation is a competitor in the life science analytical and diagnostic instruments sector, directly competing with several of Bio-Rad's product lines.
Qiagen NV
QGEN
Mkt Cap9.1B
QIAGEN is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing with Bio-Rad in the diagnostics and research sectors.
Baxter International
BAX
Mkt Cap13.62B
Baxter International operates in the medical devices and life sciences fields, competing with Bio-Rad in the broader healthcare and scientific research sectors.

About

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Show more...
CEO
Norman D. Schwartz
Employees
7450
Country
United States
ISIN
US0905721082
WKN
000862449

Listings

XNYS
US
BIO
STU
DE
BUWA.STU
MU
DE
BUWA.MU
F
DE
BUW.F

0 Comments

Share your thoughts

FAQ

What is Bio-Rad Laboratories stock price today?▼
The current price of BIO-B is $365.08 USD — it has increased by +8.33% in the past 24 hours. Watch Bio-Rad Laboratories stock price performance more closely on the chart.
What is Bio-Rad Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Bio-Rad Laboratories stocks are traded under the ticker BIO-B.
What is Bio-Rad Laboratories market cap?▼
Today Bio-Rad Laboratories has the market capitalization of 9.76B
When is the next Bio-Rad Laboratories earnings date?▼
Bio-Rad Laboratories is going to release the next earnings report on October 22, 2026.
What were Bio-Rad Laboratories earnings last quarter?▼
BIO-B earnings for the last quarter are 2.62 USD per share, whereas the estimation was 1.75 USD resulting in a +49.92% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bio-Rad Laboratories revenue for the last year?▼
Bio-Rad Laboratories revenue for the last year amounts to 2.58B USD.
What is Bio-Rad Laboratories net income for the last year?▼
BIO-B net income for the last year is 759.9M USD.
How many employees does Bio-Rad Laboratories have?▼
As of August 28, 2026, the company has 7,450 employees.
In which sector is Bio-Rad Laboratories located?▼
Bio-Rad Laboratories operates in the Health & Wellness sector.
When did Bio-Rad Laboratories complete a stock split?▼
Bio-Rad Laboratories has not had any recent stock splits.
Where is Bio-Rad Laboratories headquartered?▼
Bio-Rad Laboratories is headquartered in HERCULES, United States.